Capital Stock Capital Stock

6 Months Ended

Jun. 30, 2015

Equity [Abstract]

Capital Stock

Capital Stock

On August 20, 2013, the Board of Directors authorized the repurchase of up to $250 million in shares with no expiration date. The program's objective is to deploy our capital in a manner that benefits our shareholders and maintains our focus on growth. There were no shares repurchased under this program during the three months ended June 30, 2015. For the six months ended June 30, 2015, we repurchased 1.4 million shares for $50 million. There are up to $20 million in shares that may still be purchased under this plan as of June 30, 2015. For the three and six months ended June 30,2014, we repurchased 1.3 million and 2.6 million shares for $50 million and $100 million, respectively, under this program.

On August 18, 2012, the Board of Directors authorized the repurchase of up to 2.0 million shares of common stock with no expiration date. The program's objective is to offset dilution associated with various Xylem employee stock plans by acquiring shares in the open market from time to time. There were no shares repurchased under this program during the three and six months ended June 30,2015 and 2014. There are up to 1.0 million shares that may still be purchased under this plan as of June 30, 2015.

Aside from the aforementioned repurchase programs, we repurchased less than 0.1 million and 0.1 million shares for less than $1 million and $3 million during the three and six months ended June 30,2015, respectively, in relation to settlement of employee tax withholding obligations due as a result of the vesting of restricted stock. Likewise, during the three and six months ended June 30,2014, we repurchased less than 0.1 million shares in both periods for less than $1 million and $1 million, respectively.